Argenx Se (ARGX) Times Interest Earned (2019 - 2025)
Argenx Se's (ARGX) quarterly Times Interest Earned came in at -$389.61 in Q2 2022, up 100.0% YoY from -$194.8 in Q2 2021, and down 266.71% on a QoQ basis from $233.71 in Q1 2022.
Argenx Se (ARGX) Times Interest Earned (2019 - 2025) Analysis & Trends
Argenx Se (ARGX) has 3 years of Times Interest Earned data on file, last reported at -$389.61 in Q2 2022.
- Quarterly Times Interest Earned rose 100.0% year-over-year to -$389.61 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was -$879.17 (up 100.0% YoY) and the FY2025 annual result came in at $258.16, up 3037.58% from the prior year.
- Times Interest Earned retreated to -$389.61 in Q2 2022, from $233.71 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $233.71 in Q1 2022 to a low of -$11.0 billion in Q1 2021.
- A 3-year average of -$2.4 billion and a median of -$2751.0 in 2019 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 100.0% in 2022, down 100.0% in 2022.
- Tracing ARGX's Times Interest Earned over 3 years: stood at -$1348.9 in 2019, then plunged by 270953717.99% to -$3.7 billion in 2021, then soared by 100.0% to -$389.61 in 2022.
- The last three Times Interest Earned figures came in at -$389.61 (Q2 2022), $233.71 (Q1 2022), and -$3.7 billion (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -55.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -408.46 |
| Jun 30, 2025 | -0.30 |
| Dec 31, 2024 | -262.86 |
| Jun 30, 2024 | 0.29 |
| Dec 31, 2023 | -656.99 |
| Jun 30, 2023 | 1,308.90 |
| Dec 31, 2022 | 134.47 |
| Jun 30, 2022 | -389.61 |
| Mar 31, 2022 | 233.71 |
| Jun 30, 2021 | -3.65 Bn |
| Mar 31, 2021 | -10.98 Bn |
| Dec 31, 2019 | -1,348.85 |
| Sep 30, 2019 | -4,153.24 |